[Federal Register: September 29, 2008 (Volume 73, Number 189)]
[Notices]               
[Page 56612]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr29se08-104]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 24, 2008, Johnson 
Matthey Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West 
Deptford, New Jersey 08066-1742, made application by letter to the Drug 
Enforcement Administration (DEA) as a bulk manufacturer of Gamma-
Hydroxybutyric acid (2010), a basic class of controlled substance 
listed in schedule I.
    The company plans on producing sodium oxybate for sale to its 
customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than November 28, 2008.

    Dated: September 22, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-22874 Filed 9-26-08; 8:45 am]

BILLING CODE 4410-09-P